IN2014MU00072A - - Google Patents

Info

Publication number
IN2014MU00072A
IN2014MU00072A IN72MU2014A IN2014MU00072A IN 2014MU00072 A IN2014MU00072 A IN 2014MU00072A IN 72MU2014 A IN72MU2014 A IN 72MU2014A IN 2014MU00072 A IN2014MU00072 A IN 2014MU00072A
Authority
IN
India
Prior art keywords
rivaroxaban
preparation
pharmaceutically acceptable
acceptable salt
present
Prior art date
Application number
Inventor
Jagdish Dattopant Shukla
Ramprasad Yadav
Arvind Yekanathsa Merwade
Keshav Deo
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN72MU2014 priority Critical patent/IN2014MU00072A/en
Priority to PCT/IB2014/067072 priority patent/WO2015104605A1/en
Publication of IN2014MU00072A publication Critical patent/IN2014MU00072A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

The present invention relates to a process for the preparation of Rivaroxaban, intermediates thereof, or a pharmaceutically acceptable salt thereof. The present invention especially relates to a process for the preparation of rivaroxaban from thioester of formula IIA: Formula IIA or a pharmaceutically acceptable salt thereof.
IN72MU2014 2014-01-08 2014-12-18 IN2014MU00072A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN72MU2014 IN2014MU00072A (en) 2014-01-08 2014-12-18
PCT/IB2014/067072 WO2015104605A1 (en) 2014-01-08 2014-12-18 A process for preparing rivaroxaban or a pharmaceutically acceptable salt thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN72MU2014 IN2014MU00072A (en) 2014-01-08 2014-12-18

Publications (1)

Publication Number Publication Date
IN2014MU00072A true IN2014MU00072A (en) 2015-08-21

Family

ID=53523577

Family Applications (1)

Application Number Title Priority Date Filing Date
IN72MU2014 IN2014MU00072A (en) 2014-01-08 2014-12-18

Country Status (2)

Country Link
IN (1) IN2014MU00072A (en)
WO (1) WO2015104605A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210163423A1 (en) * 2015-02-17 2021-06-03 Neupharma, Inc. Certain chemical entities, compositions, and methods

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3740716B2 (en) * 1994-08-04 2006-02-01 和光純薬工業株式会社 Acylthiocholine derivatives and uses thereof
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
DE102004002044A1 (en) 2004-01-15 2005-08-04 Bayer Healthcare Ag manufacturing
JP2006056812A (en) * 2004-08-19 2006-03-02 Ube Ind Ltd 6,6-difluoro-5-hexene-1-thiol derivative and agricultural and horticultural pest controlling agent
DE102006048042A1 (en) * 2006-10-11 2008-04-17 Bayer Healthcare Ag Acylaminoimidazoles and acylaminothiazoles
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
ES2905760T3 (en) 2009-07-31 2022-04-12 Krka D D Novo Mesto Procedures for the crystallization of rivaroxaban
CN102822167A (en) 2010-01-04 2012-12-12 埃南蒂亚有限公司 Process for the preparation of rivaroxaban and intermediates thereof
EP2354128A1 (en) 2010-02-10 2011-08-10 Sandoz Ag Method for the preparation of rivaroxaban
US9556163B2 (en) 2011-05-06 2017-01-31 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Process for the preparation of a rivaroxaban and intermediates formed in said process
WO2012156983A1 (en) 2011-05-16 2012-11-22 Symed Labs Limited Processes for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
EP2753619A2 (en) 2011-09-08 2014-07-16 Cadila Healthcare Limited Processes and intermediates for preparing rivaroxaban
WO2013053739A1 (en) 2011-10-10 2013-04-18 Laboratorios Lesvi, S. L. Process for preparing factor xa inhibitors
CZ2012114A3 (en) 2012-02-17 2013-02-20 Zentiva, K.S. Process for preparing rivaroxaban based on saving of 1,1?-carbonyldiimidazole
US9562040B2 (en) 2012-04-06 2017-02-07 Indiana University Research And Technology Corporation Processes for preparing Rivaroxaban
AU2013250801A1 (en) 2012-04-16 2014-11-06 Sun Pharmaceutical Industries Limited Process for the preparation of rivaroxaban and intermediates thereof
CA2871339C (en) 2012-05-02 2016-08-23 Symed Labs Limited Improved process for preparing rivaroxaban
CN104098556B (en) * 2013-04-09 2019-01-08 浙江九洲药物科技有限公司 A kind of synthesis technology of razaxaban

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210163423A1 (en) * 2015-02-17 2021-06-03 Neupharma, Inc. Certain chemical entities, compositions, and methods

Also Published As

Publication number Publication date
WO2015104605A1 (en) 2015-07-16

Similar Documents

Publication Publication Date Title
MX2017006266A (en) Heteroaryl compounds as irak inhibitors and uses thereof.
MX2020001278A (en) Synthesis of polycyclic-carbamoylpyridone compounds.
GR20140100479A (en) Synthesis of liraglutide
IN2014CH00247A (en)
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
JO3487B1 (en) Synthesis of copanlisib and its dihydrochloride salt
MX2016010973A (en) Aminocarbonylcarbamate compounds.
PH12016501613A1 (en) Pyrazines modulators of gpr6
MA40312A (en) Oral pharmaceutical composition of isotretinoin
PH12017501404A1 (en) Diaza-benzofluoranthrene compounds
MX2019001228A (en) Production method for pyrazole-amide compound.
IN2014MU01192A (en)
IN2014MU00195A (en)
MX2016015298A (en) Nampt inhibitors and methods.
IN2014MU00072A (en)
IN2014MU00194A (en)
IN2014MU01196A (en)
MX2016016398A (en) Preparation of piperidine-4-carbothioamide.
MX2016015623A (en) Process for preparing dihydroisoxazole derivatives.
MX2017004770A (en) Solid forms of nilotinib hydrochloride.
IN2013MU03670A (en)
IN2014MU00070A (en)
IN2014MU00566A (en)
IN2014MU00858A (en)
IN2014MU01195A (en)